Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Osimertinib plus selumetinib in patients with EGFR-mutated advanced NSCLC with BRAF alterations post-progression on first-line osimertinib: ORCHARD.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 20, 2026
Durvalumab plus etoposide-platinum in patients with epidermal growth factor receptor (EGFR)-mutated advanced NSCLC and neuroendocrine transformation after first-line osimertinib: ORCHARD.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 13, 2026
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC after progression on first-line osimertinib: ORCHARD.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 19, 2026
Durvalumab Plus Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARD.
Journal: JTO clinical and research reports
Published: April 28, 2025
Integrated Multi-omics Analysis of Early Lung Adenocarcinoma Links Tumor Biological Features with Predicted Indolence or Aggressiveness.
Journal: Cancer research communications
Published: October 07, 2022
HLA-DR cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior.
Journal: Scientific reports
Published: December 15, 2020
A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 09, 2020
Expanding Access to Lung Cancer Clinical Trials by Reducing the Use of Restrictive Exclusion Criteria: Perspectives of a Multistakeholder Working Group.
Journal: Clinical lung cancer
Published: November 17, 2019
New Approaches to SCLC Therapy: From the Laboratory to the Clinic.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 06, 2019
Somatostatin receptor 2 targeting in small cell lung carcinoma: perspectives.
Journal: Oncotarget
Published: June 18, 2019
Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.
Journal: Nature reviews. Cancer
Published: June 09, 2019
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.
Journal: Nature reviews. Cancer
Published: March 31, 2019
Last Updated: 09/26/2026